【CEJ】The team of Central South University successfully developed a new anti-tumor immunostimulatory nanodrug

This article is the original of the translational medicine network, please indicate the source when reprinting

Author: Jevin

Recently, the School of Life Sciences of Central South University and researchers from Xiangya Hospital have successfully developed a new type of immunostimulatory nanodrug

The study, published in the Chemical Engineering Journal, focuses on the significance of novel nano-immune drugs in adenosine regulation, as well as the synergistic treatment that emphasizes photothermal therapy and immunomodulation can provide potential treatments for tumors

faces challenges

 01 

Immunotherapy strategies to kill tumors by activating the body's own immune system have been receiving sustained attention

Tumor site inhibitory immune microenvironment (TME) largely leads to a low

New nanomedicines

 02

The researchers constructed novel nanodrug Apt@SCH@BPs

Research implications

 03 

All in all, the research team has developed a novel photothermal A2AR blockade black phosphorus nanobomb that attenuates the tumor matrix and enhances the infiltration

Resources:

This article is intended to introduce medical research advances and cannot be used as a reference for

Recommended Live/Events

09/27 14:00-17:30 Shanghai

Innovative technology to facilitate the summit forum on accurate diagnosis and treatment of tumors

Scan the code to participate for free

November 03-04 09:00-17:30 Shanghai

The 3rd Yangtze River Delta In Vitro Diagnostic Industry Forum

Scan the code to participate for free

November 11-25 27:09-00:17 Shanghai

The 4th Shanghai International Cancer Congress

Scan the code to participate